APF
BIIB icon

Alaska Permanent Fund’s Biogen BIIB Stock Holding History

Alaska Permanent Fund’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,103
Closed -$1.32M – 482
2024
Q1 		$1.32M Hold
6,103
– – 0.02% 346
2023
Q4 		$1.58M Buy
+6,103
New +$1.5M 0.03% 338
2022
Q4 		$2.26M Sell
8,160
-6,919
-46% -$1.95M 0.04% 200
2022
Q3 		$4.03M Buy
15,079
+4,379
+41% +$930K 0.07% 87
2022
Q2 		$2.18M Buy
+10,700
New +$2.19M 0.03% 197
2021
Q2 		– Sell
-8,200
Closed -$2.29M – 226
2021
Q1 		$2.29M Hold
8,200
– – 0.04% 201
2020
Q4 		$2.01M Hold
8,200
– – 0.04% 204
2020
Q3 		$2.33M Buy
8,200
+4,760
+138% +$1.33M 0.04% 50
2020
Q2 		$920K Hold
3,440
– – 0.01% 74
2020
Q1 		$1.09M Buy
+3,440
New +$1.04M 0.02% 38

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alaska Permanent Fund's BIIB Position: Q2 2024 in Review

Alaska Permanent Fund sold out of Biogen (BIIB) in Q2 2024, closing a stake of 6,103 shares — an estimated $1.32M sold.

Alaska Permanent Fund first reported a position in BIIB in Q1 2020 and held it in 10 quarters. The position peaked at $4.03M in Q3 2022. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Alaska Permanent Fund reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Alaska Permanent Fund sold 6,103 Biogen shares in Q2 2024, an estimated $1.32M.
  • Alaska Permanent Fund first reported a position in Biogen in Q1 2020 and held it in 10 quarters.
  • Alaska Permanent Fund's Biogen position peaked at $4.03M in Q3 2022.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Alaska Permanent Fund's 13F filing for Q2 2024, filed 8 Aug 2024.